Laurus Labs Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| LAURUSLABS.NS | AUROPHARMA.BO | LUPIN.NS | ALKEM.NS | IPCALAB.BO | ZYDUSLIFE.BO | |
|---|---|---|---|---|---|---|
| Market cap | 1.09T | 916.88B | 898.12B | 599.62B | 486.30B | 1.11T |
| P/E (TTM) | 100.0 | 26.8 | 16.3 | 27.8 | 37.1 | 24.9 |
| Forward P/E | 67.4 | 21.0 | 19.4 | 22.4 | 27.2 | 22.7 |
| Price/book | 20.6 | 2.6 | 4.0 | 4.3 | 6.0 | 4.1 |
| Dividend yield | 0.12% | 0.33% | 0.93% | 0.40% | 0.33% | 0.09% |
| 1-year change | +123.94% | +1.70% | −0.16% | −9.58% | +42.49% | +10.44% |
| Today | −2.25% | −2.40% | +1.28% | +0.22% | +5.60% | +0.39% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All LAURUSLABS.NS news ›Laurus Labs Invests Rs 107.8 Crore in KRKA Pharma Through Rights Issue
Hyderabad: Laurus Labs Limited has invested Rs 107.8 crore in KRKA Pharma Private Limited through a rights issue, acquiring 10.78 crore equity shares at a face value of Rs 10 each. Following the investment, the company's total holding in…
Laurus Labs Ltd Hits All-Time High of Rs 2,071 as Momentum Builds Across Timeframes
Technical and Trend Analysis Growth and Profitability Trends Summary of Key Financial Indicators These figures underscore the company’s capacity to generate strong earnings and maintain operational efficiency. Market Position and Sector…
KRKA Pharma Private Limited announced that it expects to receive INR 2.22575082 billion in funding from Laurus Labs Limited, Krka, d. d.
KRKA Pharma Private Limited announced that it will issue equity share for the gross proceeds INR 2,225,750,820 on April 30, 2026. The transaction will include participation from returning investor... KRKA Pharma Private Limited announced…
Laurus Labs Invests ₹107.8 Crore In KRKA Pharma, Maintains 49% Stake
Mumbai: Laurus Labs Limited has invested ₹107.8 crore in KRKA Pharma Private Limited through a rights issue, according to a company announcement dated October 14, 2026. The pharmaceutical company acquired 10.78 crore equity shares with a…
Laurus Labs invests $11.3 million in KRKA Pharma JV
The Times of India Hyderabad: Pharma major Laurus Labs has invested around Rs 108 crore ($11.3 million) in KRKA Pharma Private Limited, its Hyderabad-based joint venture with Sloveniaâs KRKA, through a rights issue, the company said in a…
Laurus Labs receives ESG rating of 82.6 from CARE ESG Ratings
Laurus Labs Limited has been assigned an ESG rating of 82.6 by CARE ESG Ratings Limited, indicating a leadership position in managing ESG risks. Laurus Labs receives ESG rating of 82.6 from CARE ESG Ratings Laurus Labs Limited has been…
Laurus Labs LAURUSLABS Reg 74(5) Certificate Q2 FY27
Kalkine India Laurus Labs (NSE:LAURUSLABS): Has It Filed Its Q2 FY27 Depository Compliance Certificate? Source: Krish Capital Pty Ltd Laurus Labs Limited (NSE:LAURUSLABS) submitted its Regulation 74(5) compliance certificate to NSE and BSE…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
kalkine.co.in2
-
livemint.com2
-
timesofindia.indiatimes.com2
-
business-standard.com1
-
businessupturn.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 14 articles, not a forecast.